(S)-3,3'-Bis([1,1'-biphenyl]-4-yl)-[1,1'-binaphthalene]-2,2'-diol, 1g

2,6-Dichloroisonicotinamide, 95.0%, 5g

2-(4-Methoxy-3-propoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

1H-Pyrazolo[3,4-b]pyridine-3-carbonitrile, 5-fluoro-, 98%, 1g

4-(4-chlorophenyl)-1,3-thiazole-2-carbaldehyde, 250mg

Methyl 4,5-dihydroxypicolinate, 95.0%, 100mg

2-[2-(2-Methoxyethoxy)ethoxy]ethyl 4-Methylbenzenesulfonate>98.0%(HPLC)(T)1g

TRANS-4-(BENZYLOXY)CYCLOHEXANAMINE, 95.0%, 250mg

Phospholane, 1,1'-(1,2-ethanediyl)bis[2,5-dimethyl-, (2S,2'S,5S,5'S)-, 98%, 250mg

Cubreobjetos grosor 1,5 redondo, 24 mm 1000 piezas

1,7'-Dimethyl-2'-propyl-2,5'-bibenzimidazole>98.0%(HPLC)5g

Tenalisib, 25mg

3-nitrobenzene-1-carbothioamide, 95.0%, 1g